Mae gennym drefniant arbennig o gryf ar gyfer meddyginiaethau. Mae’r Grŵp Strategaeth Feddyginiaethau Cymru Gyfan (AWMSG) a’r Sefydliad Cenedlaethol dros Iechyd a Rhagoriaeth Glinigol (NICE) yn darparu cyngor awdurdodol ac arbenigol i’r GIG ynglŷn â rheoli meddyginiaethau. Mae parch mawr i’w gwaith am ei drylwyredd a’i gysondeb  rhwng arbenigeddau yng Nghymru a Lloegr. Eisoes, mae yna ddull cydymdeimladol o ymdrin â chleifion canser, sef trwy ddilyn meini prawf ‘diwedd oes’ ar gyfer cyffuriau canser.
We have a particularly strong arrangement in place for medicines.  The All Wales Medicines Strategy Group (AWMSG) and the National Institute for Health and Clinical Excellence (NICE) provide the NHS with authoritative and expert advice on the management of medicines.  Their work is highly respected for its rigour and consistency between specialities across England and Wales.  There is already a sympathetic approach to cancer patients through the application of ‘end of life’ criteria for cancer drugs.